Different types of cell death in organismal aging and longevity: State of the art and possible systems biology approach

Current Pharmaceutical Design

Volumn 14, Issue 3, 2008, Pages 226-236

  Salvioli, Stefano ^a,b,c   Capri, Miriam ^a   Tieri, Paolo ^a,b   Loroni, Jonathan ^a,b   Barbi, Cristiana ^a,b   Invidia, Laura ^a,b   Altilia, Serena ^a,b   Santoro, Aurelia ^a,b   Pirazzini, Chiara ^a,b   Pierini, Michela ^a,b   Bellavista, Elena ^a,b   Alberghina, Lilia ^d,e   Franceschi, Claudio ^a,b,c,f  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Centro Interdipartimentale L Galvani   (Italy)

^c ER GenTech Laboratory   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e Blueprint Biotech   (Italy)

^f INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; DEATH ASSOCIATED PROTEIN KINASE; DNA; EPIDERMAL GROWTH FACTOR; HEAT SHOCK PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN BCL 2; PROTEIN KINASE C EPSILON; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALLOSTASIS; APOPTOSIS; AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DEGRADATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC SUSCEPTIBILITY; HUMAN; LONGEVITY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SENESCENCE; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL MODEL; MITOSIS; PHYSIOLOGY; TIME;

AGING; ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL PROLIFERATION; HUMANS; LONGEVITY; MITOSIS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 39749152243     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783413266     Document Type: Review

References (166)

1. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Corsi MP, et al. Cell proliferation and apoptosis in the immune system in the elderty. Immunol Res 2000; 21: 31-8.
2. Schmitt CA. Cellular senescence, and cancer treatment. Biochim Biophys Acta 2007; 1775: 5-20.
3. Rattan SI. Theories of biological aging: Genes, proteins, and free radicals. Free Radic Res 2006; 40: 1230-8.
4. Gilhar A, Ullmann Y, Karry R, Shalaginov R, Assy B, Serafimovich S, et al. Ageing of human epidermis: The role of apoptosis, Fas and telomerase. Br J Dermatol 2004; 150: 56-63.
5. Wang X, Bregegere F, Soroka Y, Kayat A, Redziniak G, Milner Y. Enhancement of Fas-mediated apoptosis in ageing human keratinocytes. Mech Ageing Dev 2004; 125: 237-49.
6. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: Important role of nitric oxide. Circ Res 2001; 89: 709-15.
7. Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I, et al. Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol Cell Biol 2001; 21: 1552-64.
8. Hampel B, Malisan F, Niederegger H, Testi R, Jansen-Durr P. Differential regulation of apoptotic cell death in senescent human cells. Exp Gerontol 2004; 39: 1713-21.
9. Mondello C, Petropoulou C, Monti D, Gonos ES, Franceschi C, Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp Cell Res 1999; 248: 234-42.
10. Chondrogianni N, de C M, Simoes D, Franceschi C, Gonos ES. Cloning of differentially expressed genes in skin fibroblasts from centenarians. Biogerontology 2004; 5: 401-9.
11. Chung JW, Jeon JH, Yoon SR, Choi I. Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases. J Dermatol 2006; 33: 662-9.
12. Li M, Xiao ZQ, Chen ZC, Li JL, Li C, Zhang PF, et al. Proteomic analysis of the aging-related proteins in human normal colon epithelia tissue. J Biochem Mol Biol. 2007; 40: 72-81.
13. Bladier C, Wolvetang EJ, Hutchinson P, de Haan JB, Kola I. Response of a primary human fibroblast cell line to H2O2: Senescencelike growth arrest or apoptosis? Cell Growth Differ 1997; 8: 589-98.
14. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, et al. Role of p53 and p21 waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999; 18: 4808-18.
15. Härle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476-81.
16. Blackburn EH. Telomere states and cell fates. Nature 2000; 408: 53-6
17. Matsui M, Miyasaka J, Hamada K, Ogawa Y, Hiramoto M, Fujimori R, et al. Influence of aging and cell senescence on telomerase activity in keratinocytes. J Dermatol Sci 2000; 22: 80-7.
18. Hao ZM, Luo JY, Chong J, Li L, He D, Wang QY, et al. Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway. Cancer Biol Ther 2005; 4: 1098-103.
19. Mondello C, Chiesa M, Rebuzzini P, Zongaro S, Verri A, Colombo T, et al. Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals. Biochem Biophys Res Common 2003; 308: 914-21.
20. Klinger RY, Blum JL, Heam B, Lebow B, Niklason LE. Relevance and safety of telomerase for human tissue engineering. Proc Natl Acad Sci USA. 2006; 103: 2500-5.
21. Gialdi L, De Martinis M, Monti D, Franceschi C. The immune system in the elderly: Activation-induced and damage-induced apoptosis. Immunol Res 2004; 30: 81-94.
22. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol 2005; 26: 523-8.
23. Monti D, Troiano L, Tropea F, Grassilli E, Cossarizza A, Barozzi D, et al. Apoptosis - programmed cell death: A role in the aging process? Am J Clin Nutr 1992; 55: 1208S-14S.
24. Monti D, Salvioli S, Capri M, Malorni W, Straface E, Cossarizza A, et al. Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech Ageing Dev 2000; 121: 239-50.
25. Spaulding C, Guo W, Effros RB. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 1999; 34: 633-44.
26. Effros RB. Telomerase induction in T cells: A cure for aging and disease? Exp Gerontol 2007; 42: 416-20.
27. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G et al. Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology 1996; 88: 501-7.
28. Salvioli S, Capri M, Scarcella E, Mangherini S, Faranca I, Volterra V, et al. Age-dependent changes in the susceptibility to apoptosis of peripheral blood CD4+ and CD8+ T lymphocytes with virgin or memory phenotype. Mech Aging Dev 2003; 124: 409-18.
29. Luciani F, Valensin S, Vescovini R, Sansoni P, Fagnoni F, Franceschi C, et al. A stochastic model for CD8(+)T cell dynamics in human immunosenescence: Implications for survival and longevity. J Theor Biol 2001; 213: 587-97.
30. Hsu HC, Scott DK, Zhang P, Zhou J, Yang P, Wu Q, et al. CD8 T-cell immune phenotype of successful aging. Mech Ageing Dev 2006; 127: 231-9.
31. Brzezinska A, Magalska A, Szybinska A, Sikora E. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging. Exp Gerontol 2004; 39: 539-44.
32. Chong Y, Ikematsu H, Yamaji K, Nishimura M, Nabeshima S, Kashiwagi S, et al. CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: Implications for age-related peripheral B cell developmental disturbances. Int Immunol 2005; 17: 383-90.
33. Geigl JB, Langer S, Barwisch S, Pfleghaar K, Lederer G, Speicher MR. Analysis of gene expression patterns and chromosomal changes associated with aging Cancer Res 2004; 64: 8550-7.
34. Hsu HC, Scott DK, Mountz JD. Impaired apoptosis and immune senescence - cause or effect? Immunol Rev 2005; 205: 130-46.
35. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18: 1717-20.
36. Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, et al. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol 2004; 39: 1233-43.
37. Feng L, Hollstein M, Xu Y. Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle 2006; 5: 2812-9.
38. Jackson JG, Pereira-Smith OM. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Res 2006; 66: 8356-60
39. Donehower LA. p53: Guardian AND suppressor of longevity? Exp Gerontol 2005; 40: 7-9.
40. Mayelzadeh F, Martinez JD. DNA binding and selective gene induction by different forms of the p53 protein. Oncogene 2007; 26: 2955-63.
41. Bonafe M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, et al. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochem Biophys Res Commun 2002; 299: 539-41.
42. Bonafe M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, et al. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 2004; 11: 962-73.
43. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 2004; 23: 3328-37.
44. Salvioli S, Bonafe M, Barbi C, Storci G, Trapassi C, Tocco F, et al. p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1. Cell Cycle 2005; 4:1264-71.
45. Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D, et al. The genetics of human longevity. Ann N Y Acad Sci 2006; 106: 252-63.
46. De Benedictis G, Franceschi C. The unusual genetics of human longevity. Sci Aging Knowledge Environ 2006; 2006: Pe20.
47. Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins. Br J Cancer 2006; 95: 520-4.
48. Serrano M. Cancer regression by senescence. N Engl J Med 2007; 356: 1996-7.
49. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst M, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436: 720-4.
50. Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6: 472-6.
51. Warner HR. Is cell death and replacement a factor in aging? Mech Aging Dev 2007; 128: 13-6.
52. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072-7.
53. Campisi J. Suppressing cancer: The importance of being senescent. Science 2005; 309: 896-7.
54. Franceschi C. Cell proliferation, cell death and aging. Aging (Milano). 1989; 1: 3-15.
55. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J 1997; 328:721-32.
56. Wojcik C, DeMartino GN. Intracellular localization of proteasomes. Int J Biochem Cell Biol 2003; 35: 579-89.
57. Cuervo AM, Palmer A, Rivett AJ, Knecht E. Degradation of proteasomes by lysosomes in rat liver, Eur J Biochem 1995; 227: 792-800.
58. Cuervo AM. Autophagy: Many paths to the same end. Mol Cell Biochem 2004; 263: 55-72.
59. Scott RC, Schuldiner O, Neufeld TP. Role and regulation of starvation-induced autophagy in the Drosophila fat body. Dev Cell 2004; 7: 167-78.
60. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T et al. Growth factor regalation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-48.
61. Boya RA, Gonzalez-Polo N, Casares JL, Perfettini P, Dessen N, Larochette D, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005; 25: 1025-40.
62. Jolly RD, Palmer DN, Dalefield RR. The analytical approach to the nature of lipofuscin (age pigment). Arch Gerontol Geriatr 2002; 34: 205-17
63. Shintani T, Klionsky DJ. Autophagy in health and disease: A double-edged sword. Science 2004; 306: 990-5.
64. Stroikin Y, Dalen H, Brunk UT, Terman A. Testing the "garbage" accumulation theory of ageing: Mitotic activity protects cells from death induced by inhibition of autophagy. Biogerontology 2005; 6: 39-47.
65. Hars ES, Qi H, Ryazanov AG, Jin S, Cai L, Hu C, et al. Autophagy regulates ageing in C. elegans. Autophagy 2007; 3: 93-5.
66. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301: 1387-91.
67. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13(5):619-24.
68. Poppek D, Grune T. Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 2006; 8: 173-84.
69. Tanahashi-Hori T, Tanahashi N, Tanaka K, Chiba T. Conditional knockdown of proteasomes results in cell-cycle arrest and enhanced expression of molecular chaperones Hsp70 and Hsp40 in chicken DT40 cells. J Biol Chem 2003; 278: 16237-43.
70. Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 2000; 35: 721-8.
71. Mishto M, Santoro A, Bellavista E, Bonafe M, Monti D, Franceschi C. Immunoproteasomes and immunosenescence. Aging Res Rev 2003; 2: 419-32.
72. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damage mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002; 269: 1996-2002.
73. Terman A, Gustafsson B, Brunk UT. Autophagy, organelles and ageing. J Pathol 2007; 211: 134-43.
74. Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: Cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 2003; 88: 3299-304.
75. Barbieri M, Bonafe M, Franceschi C, Paolisso G. Insulin/IGF-I-signaling pathway: An evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 2003; 285: E1064-71.
76. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284: E481-7.
77. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L., Capri M, et al. Genes involved in immune response/inflammation, IGF1/ insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: The lesson of centenarians. Mech Ageing Dev 2005; 126: 351-61.
78. Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A. Autophagy and aging. Autophagy 2095; 181: 131-40.
79. Meijer AJ, Codogno P. Signalling and autophagy regulation in health, aging and disease. Mol Aspects Med 2006; 27: 411-25.
80. Bergamini E, Cavallini G, Donati A, Gori Z. The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically. Biomed Pharmacother 2004; 57: 203-8.
81. Takacs-Vellai K, Bayci A, Vellai T. Autophagy in neuronal cell loss: A road to death. Bioessays 2006; 28: 1126-31.
82. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Icssi E, et al. Cannibalism of live lymphocytes by hu,an metastatic but not primary melanoma cells. Cancer Res 2006; 66: 3629-38.
83. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
84. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA 2002; 99: 13653-8.
85. Hajnocz-ky G, Hoek JB. Cell signaling. Mitochondrial longevity pathways. Science 2007; 315: 607-9.
86. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 2003; 3 8: 1065-70.
87. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, et al. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 2004; 279: 25689-95.
88. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, et al. The p66she adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309-13.
89. Nemoto S, Combs CA, French 8, Ahn BH, Fergusson MM, Balaban RS, et al. The mammalian longevity-associated gene product p66she regulates mitochondrial metabolism. J Biol Chem 2006; 281: 10555-60.
90. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221-33.
91. Jin S. Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2006; 2: 80-4.
92. Cavallini G, Donati A, Taddei M, Bergamini E. Evidence for selective mitochondrial autophagy and failure in aging. Autophagy 2007; 3: 26-7.
93. Camougrand N, Kissova I, Velours G, Manon S. Uth1p: A yeast mitochondrial protein at the crossroads of stress, degradation and cell death. FEMS Yeast Res 2004; 5: 133-40.
94. Kissova I, Deffieu M, Manon S, Camougrand N. Uth1p is involved in the autophagic degradation of mitochondria. J Biol Chem 2004; 279: 39068-74.
95. Terman A, Gustafsson B, Brunk UT. Mitochondrial damage and intralysosomal degradation in cellular aging. Mol Aspects Med 2006; 27: 471-82.
96. Arnold I, Langer T. Membrane protein degradation by AAA proteases in mitochondria. Biochim Biophys Acta 2002; 1592: 89-96.
97. Bakala H, Delaval E, Hamelin M, Bismuth J, Borot-Laloi C, Corman B, et al. Changes in rat liver mitochondria with aging. Lon protease-like reactivity and N(epsilon)-carboxymethyllysine accumulation in the matrix. Eur J Biochem 2003; 270: 2295-302.
98. Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002; 4: 674-80.
99. Chen XJ, Butow RA. The organization and inheritance of the mitochondrial genome. Nat Rev Genet 2005; 6: 815-25.
100. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun 2003; 304: 519-29.
101. Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafe M, Olivieri F, et al. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci USA 2003; 100: 1116-21.
102. Bota DA, Ngo JK, Davies KJ. Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radic Biol Med 2005; 38: 665-77.
103. Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 2002; 532: 103-6.
104. Marzetti E, Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol 2006; 41: 1234-8.
105. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110: 177-89.
106. Kim DH, SarbassovDD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110: 163-75.
107. Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102: 8204-9
108. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126: 121-34.
109. Bonafe M, Barbi C, Storci G, Salvioli S, Capri M, Olivieri F, et al. What studies on human longevity tell us about the risk for cancer in the oldest old: Data and hypotheses on the genetics and immunology of centenarians. Exp Gerontol 2002; 37: 1263-71.
110. Cuervo AM. Autophagy: In sickness and in health. Trends Cell Biol 2004b; 14: 70-7.
111. Mariño G, López-Otin C. Autophagy: Molecular mechanisms, physiological functions and relevance in human pathology. Cell Mol Life Sci 2004; 61:1439-54.
112. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autopbagy. Dev Cell 2004; 6: 463-77.
113. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, et al. Selective disruption of lysosomes in Hela cells triggers apoptosis mediated by cleavage of bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279: 3578-87.
114. Feldstein AE, Werneburg NW, Li Z, Bronk SF, Gores GJ. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1339-46.
115. Zhao M, Brunk UT, Eaton JW. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 2001; 509: 399-404.
116. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: A review. Clin Cancer Res 2005; 11: 3155-62.
117. Kagedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 2001; 359: 335-43.
118. Chen W, Li N, Chen T, Han Y, Li C, Wang Y, et al. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway. J Biol Chem 2005; 280: 40985-95.
119. Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 2002; 157: 455-68.
120. Bialik S, Kimchi A. The death-associated protein kinases: Structure, function, and beyond. Annu Rev Biochem 2006; 75: 189-210.
121. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bc1-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
122. Gerland LM, Genestier L, Peyrol S, Michallet MC, Hayette S, Urbanowicz I, et al. Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells. Exp Gerontol 2004; 39: 789-800.
123. Gerfand LM, Peyrol S, Lallemand C, Branche R, Mgaud JP, Ffrench M. Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp Gerontol 2003; 38: 887-95.
124. Stroikin Y, Johansson U, Asplund S, Ollinger K. Increased resistance of lipofuscin-loaded prematurely senescent fibroblasts to starvation-induced programmed cell death, Biogerontology 2007; 8: 43-53.
125. Paolisso G, Barbieri M, Rizzo MR, Carella C, Rotondi M, Bonafe M, et al. Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. Exp Gerontol 2001; 37: 149-56.
126. Adams J. The proteasome: Structure, function, and role in the cell. Cancer Treat Rev 2003; 29 Suppl 1: 3-9.
127. Strauss SJ, Higginbottom K, Juliger S, Maharaj L, Allen P, Schenkein D, et al. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell fines. Cancer Res 2007; 67: 2783-90
128. Carrad G, Bulteau AL, Petropoulos I, Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 2002; 34: 1461-74.
129. Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, et al. Bortezomib as an antitumor agent. Curr Pharm Biotechnol 2006; 7: 441-8.
130. Bonvini P, Zorzi E, Basso G, Rosolen A. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 2007; 21: 838-42.
131. Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J Neurosci Res 2000; 59: 601-11.
132. Pasquini LA, Besio Moreno M, Lopez Salon M, Soto EF. Apoptosis in schwann cell cultures is closely interrelated with the activity of the ubiquitin-proteasome proteolytic pathway. Neurochem Res 2002; 27: 1401-19.
133. Staropoli F, Abeliovich A. The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons. J Mol Neurosci 2005; 27: 175-83.
134. Kitano H. Systems Biology: A brief overview. Science 2002; 295: 1662-4.
135. Hua F, Hautaniemi S, Yokoo R, Lauffenburger DA. Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways. J R Soc Interface 2006; 3: 515-26.
136. Janes KA, Yaffe MB. Data-driven modelling of signal-transduction networks. Nat Rev Mol Cell Biol 2006; 7: 820-8.
137. Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and Regression Trees. Chapman & Hall, London, 1984.
138. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005; 310: 1646-53.
139. Alberghina L, Colangelo AM. The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration. BMC Neurosci 2006; 7 Suppl 1: S2.
140. Alberghina L, Porro D, Cazzador L. Towards a blueprint of the cell-cycle. Oncogene 2001; 20: 1128-34.
141. Alberghina L, Rossi RL, Porto D, Vanoni M. A modular systems biology analysis of cell cycle entrance in S phase. In systems biology: Definitions and perspectives (L. Alberghina and H. Westerhoff editors) - Topics in Current Genetics 2005; 13: 325-47, Springer Verlag
142. Barberis M, Klipp E, Vanoni M, Alberghina L. Cell size at S phase initiation: An emergent property of the G1/S network. PLoS Comput Biol 2007; 3: 64.
143. Bentele M, Lavrik I, Ulrich M, Stosser S, Heermann DW, Kalthoff H, et al. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol 2004; 166: 839-51.
144. Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH. Analysis of CD95 threshold signaling: Triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 2007; 282: 13664-71.
145. Eissing T, Colzemann H, Gilles ED, Allgower F, Bullinger E, Scheurich P. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J Biol Chem 2004; 279: 36892-7.
146. Eissing T, Allgower F, Bullinger E. Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise. Syst Biol 2005; 152: 221-8.
147. Eissing T, Waldherr S, Allgower F, Scheurich P, Bollinger E. Response to bistability in apoptosis: Roles of bax, bc1-2, and mitochondrial permeability transition pores. Biophys J 2007; 92: 3332-4.
148. Bagci EZ, Vodovotz Y, Bilhar TR, Ermentrout GB, Bahar I. Bistability in apoptosis: Roles of Bax, Bc1-2 and mitochondrial permeability transition pores. Biophys J 2006; 90: 1546-59.
149. Huber HJ, Rehm M, Plchut M, Dussmann H, Rrehn JH. APOPTOCELL - a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis. Bioinformatics 2007; 23: 648-50.
150. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci USA 2005; 102: 7653-8.
151. Kitakaze H, Matsuno H, Ikeda N, Miyano S. Prediction of debacle points for robustness of biological pathways by using recurrent neural networks. Genome Inform 2005; 16: 192-202.
152. Park SG, Lee T, Kang HY, Park K, Cho KH, Jung G. The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: A systems biology approach. FEBS Lett 2006; 580: 822-30.
153. Alberghina L, Vai M, Vanoni M. Probing control mechanisms of cell cycle and ageing in budding yeast. Curr Genomics 2004; 5: 615-627.
154. Ben-Porath I, Weinberg RA. When cells get stressed: An integrative view of cellular senescence. J Clin Invest 2004; 113, 8-13.
155. Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biology 2007; 5: 1138-51.
156. Proctor CJ, Soti C, Boys RJ, Gillespie CS, Shanley DP, Wilkinson DJ, et al. Modelling the actions of chaperones and their role in ageing. Mech Aging Dev 2005; 126: 119-31.
157. Bentele M, Eils R. Systems biology of apoptosis, in systems biology - Definitions and perspectives, alberghina L, Westerhoff HV, eds. Topics in Current Genetics, 2005; 13: 349-72.
158. Janes KA, Lauffenburger DA. A biological approach to computational models of proteomic networks. Curr Opin Chem Biol 2006; 10: 73-80.
159. Noble D. The rise of computational biology. Nat Rev Mol Cell Biol 2002; 3: 459-63.
160. Noble D. The music of life. Biology beyond the genome, Oxford University Press 2006.
161. Simon HU. Targeting apoptosis in the control of inflammation. Eur Respir J 2003; 22: 20S-21S.
162. Bamberger ME, Landreth GE. Inflammation, apoptosis, and alzheimer's disease. Neuroscientist 2002; 8: 276-83.
163. van der Woude CJ1, Kleibeuker JH, Jansen PLM, Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 2004; 9: 123-30.
164. de la Lastra CA, Villegas I, Sanchez-Fidalgo S. Poly(ADP-ribose) polymerase inhibitors: New pharmacological functions and potential clinical implications. Curr Pharm Des 2007; 13(9): 933-62.
165. Rodriguez-Nieto S, Zhivotovsky B. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 2006; 12(34): 4411-25.
166. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS. The voltage-dependent anion channel (VDAC): Function in intracellular signalling, cell life and cell death. Curr Pharm Des 2006; 12(18): 2249-70.